|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―May―19 |
Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants |
Yaning Li, Qing Fan, Bing Zhou, Yaping Shen, Yuanyuan Zhang, Lin Cheng, et al. (+6) Furong Qi, Shuo Song, Yingying Guo, Renhong Yan, Bin Ju, Zheng Zhang |
2 |
[GO] |
2022―May―18 |
Pearson’s patterns correlational of clinical risks at admissions with hospitalization outcomes during initial COVID-19 outbreak |
Jingwen Li, Xi Long, Qing Zhang, Xi Fang, Huiling Luo, Fang Fang, et al. (+8) Xuefei Lv, Dandan Zhang, Yu Sun, Na Li, Shaoping Hu, Jinghong Li, Nian Xiong, Zhicheng Lin |
3 |
[GO] |
2022―May―04 |
SARS-CoV-2-related pangolin coronavirus exhibits similar infection characteristics to SARS-CoV-2 and direct contact transmissibility in hamsters |
Zhendong Guo, Cheng Zhang, Chunmao Zhang, Huan Cui, Zhaoliang Chen, Xinyun Jiang, et al. (+8) Tiecheng Wang, Yuanguo Li, Jun Liu, Zhonghai Wan, Keyin Meng, Jiping Li, Yigang Tong, Yuwei Gao |
4 |
[GO] |
2022―Apr―28 |
EVIDENCE SHOWING LIPOTOXICITY WORSENS OUTCOMES IN COVID-19 PATIENTS AND INSIGHTS ABOUT THE UNDERLYING MECHANISMS |
Rodrigo Cartin-Ceba, Biswajit Khatua, Bara El-Kurdi, Shubham Trivedi, Sergiy Kostenko, Zaid Imam, et al. (+16) Ryan Smith, Christine Snozek, Sarah Navina, Vijeta Sharma, Bryce McFayden, Filip Ionescu, Eugene Stolow, Sylvia Keiser, Aziz Tejani, Allison Harrington, Phillip Acosta, Saatchi Kuwelker, Juan Echavarria, Girish B. Nair, Adam Bataineh, Vijay P. Singh |
5 |
[GO] |
2022―Apr―27 |
Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection |
Qiqi Zeng, Xin Qi, Junpeng Ma, Fang Hu, Xiaorui Wang, Hongyu Qin, et al. (+20) Mengyang Li, Shaoxin Huang, Yong Yang, Yixin Li, Han Bai, Meng Jiang, Doudou Ren, Ye Kang, Yang Zhao, Xiaobei Chen, Xi Ding, Di Ye, Yankui Wang, Jianguo Jiang, Dong Li, Xi Chen, Ke Hu, Binghong Zhang, Bingyin Shi, Chengsheng Zhang |
6 |
[GO] |
2022―Apr―26 |
The effect of the Delta SARS-CoV-2 variant in maternal infection and pregnancy |
Athina Samara, Asma Khalil, Patrick O’ Brien, Eric Herlenius |
7 |
[GO] |
2022―Apr―25 |
Inhibitors of dihydroorotate dehydrogenase cooperate with Molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication |
Kim M. Stegmann, Antje Dickmanns, Natalie Heinen, Claudia Blaurock, Tim Karrasch, Angele Breithaupt, et al. (+19) Robert Klopfleisch, Nadja Uhlig, Valentina Eberlein, Leila Issmail, Simon T. Herrmann, Amelie Schreieck, Evelyn Peelen, Hella Kohlhof, Balal Sadeghi, Alexander Riek, John R. Speakman, Uwe Groß, Dirk Görlich, Daniel Vitt, Thorsten Müller, Thomas Grunwald, Stephanie Pfaender, Anne Balkema-Buschmann, Matthias Dobbelstein |
8 |
[GO] |
2022―Apr―11 |
Synthetic Carbohydrate Binding Agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2. |
Oscar Francesconi, Lorena Donnici, Marco Fragai, Elisa Pesce, Mauro Bombaci, Alessandra Fasciani, et al. (+6) Lara Manganaro, Matteo Conti, Renata Grifantini, Raffaele De Francesco, Cristina Nativi, Stefano Roelens |
9 |
[GO] |
2022―Apr―11 |
Inflammatory Responses in the Placenta upon SARS-CoV-2 Infection Late in Pregnancy |
Lissenya B. Argueta, Lauretta A. Lacko, Yaron Bram, Takuya Tada, Lucia Carrau, André Figueiredo Rendeiro, et al. (+20) Tuo Zhang, Skyler Uhl, Brienne C. Lubor, Vasuretha Chandar, Cristianel Gil, Wei Zhang, Brittany J. Dodson, Jeroen Bastiaans, Malavika Prabhu, Sean Houghton, David Redmond, Christine M. Salvatore, Yawei J. Yang, Olivier Elemento, Rebecca N. Baergen, Benjamin R. tenOever, Nathaniel R. Landau, Shuibing Chen, Robert E. Schwartz, Heidi Stuhlmann |
10 |
[GO] |
2022―Apr―08 |
The value of longitudinal clinical data and paired CT scans in predicting the deterioration of COVID-19 revealed by an artificial intelligence system |
Xiaoyang Han, Ziqi Yu, Yaoyao Zhuo, Botao Zhao, Yan Ren, Lorenz Lamm, et al. (+6) Xiangyang Xue, Jianfeng Feng, Carsten Marr, Fei Shan, Tingying Peng, Xiao-Yong Zhang |
11 |
[GO] |
2022―Apr―04 |
Unraveling the motivational secrets of honey bee foraging during the COVID pandemic |
Louise Bestea, Marco Paoli, Patrick Arrufat, Brice Ronsin, Julie Carcaud, Jean-Christophe Sandoz, et al. (+3) Rodrigo Velarde, Martin Giurfa, Maria Gabriela de Brito Sanchez |
12 |
[GO] |
2022―Apr―02 |
Poly(I:C) Enhances Mesenchymal Stem Cell Control of Myeloid Cells From COVID-19 Patients |
Luciana Souza-Moreira, Yuan Tan, Yan Wang, Jia-Pey Wang, Mahmoud Salkhordeh, Jennifer Virgo, et al. (+7) Maria Florian, Aidan B.P. Murray, Irene Watpool, Lauralyn McIntyre, Shane English, Duncan J. Stewart, Shirley H.J. Mei |
13 |
[GO] |
2022―Mar―26 |
Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 lineages Gamma and P.2 in Brazil |
Tiago Gräf, Gonzalo Bello, Felipe Gomes Naveca, Marcelo Gomes, Vanessa Leiko Oikawa Cardoso, Alexandre Freitas da Silva, et al. (+13) Filipe Zimmer Dezordi, Mirleide Cordeiro dos Santos, Katia Correa de Oliveira Santos, Érika Lopes Rocha Batista, Alessandro Leonardo Álvares Magalhães, Fernando Vinhal, Fábio Miyajima, Helisson Faoro, Ricardo Khouri, Gabriel Luz Wallau, Edson Delatorre, Marilda Mendonça Siqueira, Paola Cristina Resende |
14 |
[GO] |
2022―Mar―22 |
Identified human breastmilk compositions effectively inhibit SARS-CoV-2 and variants infection and replication |
Xinyuan Lai, Yanying Yu, Wei Xian, Fei Ye, Xiaohui Ju, Yuqian Luo, et al. (+8) Huijun Dong, Yi-Hua Zhou, Wenjie Tan, Hui Zhuang, Tong Li, Xiaoyun Liu, Qiang Ding, Kuanhui Xiang |
15 |
[GO] |
2022―Mar―17 |
Computed Tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates |
Thibaut Naninck, Nidhal Kahlaoui, Julien Lemaitre, Pauline Maisonnasse, Antoine De Mori, Quentin Pascal, et al. (+14) Vanessa Contreras, Romain Marlin, Francis Relouzat, Benoît Delache, Cécile Hérate, Yoann Aldon, Marit van Gils, Nerea Zabaleta, Raphaël Ho Tsong Fang, Nathalie Bosquet, Rogier W. Sanders, Luk H. Vandenberghe, Catherine Chapon, Roger Le Grand |
16 |
[GO] |
2022―Mar―17 |
Mono- and combinational drug therapies for global viral pandemic preparedness |
Aleksandr Ianevski, Rouan Yao, Ronja M. Simonsen, Vegard Myhre, Erlend Ravlo, Gerda D. Kaynova, et al. (+12) Eva Zusinaite, Judith M. White, Stephen J. Polyak, Valentyn Oksenych, Marc P. Windisch, Qiuwei Pan, Eglė Lastauskienė, Astra Vitkauskienė, Algimantas Matukevičius, Tanel Tenson, Magnar Bjørås, Denis E. Kainov |
17 |
[GO] |
2022―Mar―14 |
Association of high SARS-CoV-2 RNAemia with diabetes and mortality in COVID-19 critically ill patient. |
Mehran Monchi, Thomas Bruneau, Sebastien Jochmans, David Veyer, Aurelia Pitsch, Olivier Ellrodt, et al. (+6) Marie Picque, Valérie Taly, Oumar Sy, Sandie Mazerand, Sylvain Diamantis, Hélène Péré |
18 |
[GO] |
2022―Mar―11 |
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants |
Qingtai Liang, Yifeng Wang, Shuyuan Zhang, Jing Sun, Wenbo Sun, Jizhou Li, et al. (+21) Yaping Liu, Mingxi Li, Lin Cheng, Yuhang Jiang, Ruoke Wang, Rui Zhang, Zihan Yang, Yifei Ren, Peng Chen, Peng Gao, Huayuan Yan, Zheng Zhang, Qi Zhang, Xuanling Shi, Jianbin Wang, Wanli Liu, Xinquan Wang, Bo Ying, Jincun Zhao, Hai Qi, Linqi Zhang |
19 |
[GO] |
2022―Mar―11 |
Detection of SARS-CoV-2 with RAPID: a prospective cohort study |
Marcelo D.T. Torres, Lucas F. de Lima, André L. Ferreira, William R. de Araujo, Paul Callahan, Antonio Dávila, et al. (+2) Benjamin S. Abella, Cesar de la Fuente-Nunez |
20 |
[GO] |
2022―Mar―10 |
ACE2 overexpressing mesenchymal stem cells alleviates COVID-19 lung injury by inhibiting pyroptosis |
Jinhuan Wei, Rui Shang, Jiaqi Wang, Shengze Zhu, JianQiang Yin, Ying Chen, et al. (+2) Yayu Zhao, Gang Chen |
21 |
[GO] |
2022―Mar―07 |
An artificial intelligence deep learning platform achieves high diagnostic accuracy for Covid-19 pneumonia by reading chest X-ray images |
Dongguang Li, Shaoguang Li |
22 |
[GO] |
2022―Feb―26 |
When do children avoid infection risks: Lessons for schools during the COVID-19 pandemic |
Nina H. Fefferman, Katy-Ann Blacker, Charles A. Price, Vanessa LoBue |
23 |
[GO] |
2022―Feb―23 |
Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern |
Anuradha Rao, Leda Bassit, Jessica Lin, Kiran Verma, Heather B. Bowers, Kimberly Pachura, et al. (+10) Morgan Greenleaf, Julie Sullivan, Eric Lai, Richard S. Creager, Thomas Pribyl, John Blackwood, Anne L. Piantadosi, Raymond Schinazi, Greg S. Martin, Wilbur A. Lam |
24 |
[GO] |
2022―Feb―22 |
Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses |
Zhao Ni Wang, Xiang Sheng Yang, Jing Sun, Jin Cun Zhao, Nan Shan Zhong, Xiao Xiao Tang |
25 |
[GO] |
2022―Feb―22 |
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants |
Jules B. Weinstein, Timothy A. Bates, Hans C. Leier, Savannah K. McBride, Eric Barklis, Fikadu G. Tafesse |
26 |
[GO] |
2022―Feb―19 |
No substantial pre-existing B cell immunity against SARS-CoV-2 in healthy adults |
Meryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, Nareshkumar Poopalasingam, Susanne Detmer, Manuel Koch, et al. (+14) Michael Korenkov, Sandro Halwe, Michael Klüver, Veronica Di Cristanziano, Hanna Janicki, Maike Schlotz, Johanna Worczinski, Birgit Gathof, Henning Gruell, Matthias Zehner, Stephan Becker, Kanika Vanshylla, Christoph Kreer, Florian Klein |
27 |
[GO] |
2022―Feb―17 |
Impact of New Variants on SARS-CoV-2 Infectivity and Neutralization: A Molecular Assessment of the Alterations in the Spike-Host Protein Interactions |
Mary Hongying Cheng, James M. Krieger, Anupam Banerjee, Yufei Xiang, Burak Kaynak, Yi Shi, et al. (+2) Moshe Arditi, Ivet Bahar |
28 |
[GO] |
2022―Feb―17 |
SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response |
Chanchan Xiao, Lipeng Mao, Zhigang Wang, Lijuan Gao, Guodong Zhu, Jun Su, et al. (+12) Xiongfei Chen, Jun Yuan, Yutian Hu, Zhinan Yin, Jun Xie, Weiqing Ji, Haitao Niu, Feng Gao, Oscar Junhong Luo, Lianbo Xiao, Pengcheng Wang, Guobing Chen |
29 |
[GO] |
2022―Feb―12 |
Modeling potential impact of COVID-19 pandemic on global electric vehicle supply chain |
Xin Sun, Gang Liu, Han Hao, Zongwei Liu, Fuquan Zhao |
30 |
[GO] |
2022―Feb―05 |
Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa |
Olayinka Sunday Okoh, Nicholas Israel Nii-Trebi, Abdulrokeeb Jakkari, Tosin Titus Olaniran, Tosin Yetunde Senbadejo, Anna Aba Kafintu-kwashie, et al. (+10) Emmanuel Oluwatobi Dairo, Tajudeen Oladunni Ganiyu, Ifiokakaninyene Ekpo Akaninyene, Louis Odinakaose Ezediuno, Idowu Jesulayomi Adeosun, Michael Asebake Ockiya, Esther Moradeyo Jimah, David J. Spiro, Elijah Kolawole Oladipo, Nídia S. Trovão |
31 |
[GO] |
2022―Feb―02 |
HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19 |
Liqun Zhang, Santosh K. Ghosh, Shrikanth C. Basavarajappa, Yinghua Chen, Pravesh Shrestha, Jackson Penfield, et al. (+4) Ann Brewer, Parameswaran Ramakrishnan, Matthias Buck, Aaron Weinberg |
32 |
[GO] |
2022―Jan―31 |
The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates the immunoregulatory/inflammatory signals |
Veronica Bordoni, Giulia Matusali, Davide Mariotti, Manuela Antonioli, Eleonora Cimini, Alessandra Sacchi, et al. (+9) Eleonora Tartaglia, Rita Casetti, Germana Grassi, Stefania Notari, Concetta Castilletti, Gian Maria Fimia, Maria Rosaria Capobianchi, Giuseppe Ippolito, Chiara Agrati |
33 |
[GO] |
2022―Jan―30 |
CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus |
Kazuto Yoshimi, Kohei Takeshita, Seiya Yamayoshi, Satomi Shibumura, Yuko Yamauchi, Masaki Yamamoto, et al. (+3) Hiroshi Yotsuyanagi, Yoshihiro Kawaoka, Tomoji Mashimo |
34 |
[GO] |
2022―Jan―28 |
Attenuation of SARS-CoV-2 Infection by Losartan in Human Kidney Organoids |
Waleed Rahmani, Hyunjae Chung, Sarthak Sinha, Maxwell Bui-Marinos, Rohit Arora, Arzina Jaffer, et al. (+3) Jennifer A. Corcoran, Jeff Biernaskie, Justin Chun |
35 |
[GO] |
2022―Jan―10 |
Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19. |
Nikhil Shri Sahajpal, Chi-Yu Jill Lai, Alex Hastie, Ashis K. Mondal, Siavash Raeisi Dehkordi, Caspar I. van der Made, et al. (+20) Olivier Fedrigo, Farooq Al-Ajli, Sawan Jalnapurkar, Marta Byrska-Bishop, Rashmi Kanagal-Shamanna, Brynn Levy, Maximilian Schieck, Thomas Illig, Silviu-Alin Bacanu, Janet S. Chou, Adrienne G. Randolph, Amyn M. Rojiani, Michael C. Zody, Catherine A. Brownstein, Alan H. Beggs, Vineet Bafna, Erich D. Jarvis, Alexander Hoischen, Alka Chaubey, Ravindra Kolhe |
36 |
[GO] |
2022―Jan―07 |
Immunity to SARS-CoV-2 up to 15 months after infection |
Harold Marcotte, Antonio Piralla, Fanglei Zuo, Likun Du, Irene Cassaniti, Hui Wan, et al. (+27) Makiko Kumagai-Braesh, Juni Andréll, Elena Percivalle, Josè Camilla Sammartino, Yating Wang, Stelios Vlachiotis, Janine Attevall, Federica Bergami, Alessandro Ferrari, Marta Colaneri, Marco Vecchia, Margherita Sambo, Valentina Zuccaro, Erika Asperges, Raffaele Bruno, Tiberio Oggionni, Federica Meloni, Hassan Abolhassani, Federico Bertoglio, Maren Schubert, Luigi Calzolai, Luca Varani, Michael Hust, Yintong Xue, Lennart Hammarström, Fausto Baldanti, Qiang Pan-Hammarström |
37 |
[GO] |
2022―Jan―05 |
Neutralization of SARS-CoV-2 Delta variant is increased after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination |
Markus Bauswein, David Peterhoff, Annelie Plentz, Andreas Hiergeist, Ralf Wagner, André Gessner, et al. (+3) Bernd Salzberger, Barbara Schmidt, Stilla Bauernfeind |
38 |
[GO] |
2022―Jan―01 |
SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics |
Karthik Ramachandran, Soumya Maity, Alagar R. Muthukumar, Soundarya Kandala, Dhanendra Tomar, Tarek Mohamed Abd El-Aziz, et al. (+16) Cristel Allen, Yuyang Sun, Manigandan Venkatesan, Travis R. Madaris, Kevin Chiem, Rachel Truitt, Neelanjan Vishnu, Gregory Aune, Allen Anderson, Luis Martinez, Wenli Yang, James D. Stockand, Brij B. Singh, Subramanya Srikantan, W. Brian Reeves, Muniswamy Madesh |
39 |
[GO] |
2021―Dec―31 |
ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection |
Zai Wang, Tingting Deng, Yulian Zhang, Wenquan Niu, Qiangqiang Nie, Shengnan Yang, et al. (+5) Peipei Liu, Pengfei Pei, Long Chen, Haibo Li, Bin Cao |
40 |
[GO] |
2021―Dec―24 |
Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection |
Qi Cui, Gustavo Garcia, Mingzi Zhang, Cheng Wang, Hongzhi Li, Tao Zhou, et al. (+3) Guihua Sun, Vaithilingaraja Arumugaswami, Yanhong Shi |
41 |
[GO] |
2021―Dec―24 |
Humoral and Cellular Immunogenicity two months after SARS-CoV-2 messenger RNA Vaccines in Patients with Cancer |
Natacha Bordry, Alfredo Addeo, Cyril Jaksic, Valérie Dutoit, Pascale Roux-Lombard, Dimpy P. Shah, et al. (+13) Pankil K. Shah, Angèle Gayet-Ageron, Alex Friedlaender, Sébastien Bugeia, Garance Gutknecht, Anna Battagin, Maragrazia Di Marco, Pierre-Francois Simand, Intidhar Ladibi-Galy, Sarah Fertani, José Sandoval, Pierre-Yves Dietrich, Nicolas Mach |
42 |
[GO] |
2021―Dec―20 |
Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19 |
Julie C. Wilson, David Kealy, Sally R. James, Tobias Plowman, Katherine Newling, Christopher Jagger, et al. (+15) Kara Filbey, Elizabeth R. Mann, Joanne E. Konkel, Madhvi Menon, Sean B. Knight, Angela Simpson, Aliya Prihartadi, Greg Forshaw, Neil Todd, David R.A. Yates, John R. Grainger, Tracy Hussell, Paul M. Kaye, Nathalie Signoret, Dimitris Lagos |
43 |
[GO] |
2021―Dec―20 |
ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2 |
Naoki Iwanaga, Laura Cooper, Lijun Rong, Nicholas J. Maness, Brandon Beddingfield, Zhongnan Qin, et al. (+13) Jackelyn Crabtree, Ralph A. Tripp, Haoran Yang, Robert Blair, Sonia Jangra, Adolfo García-Sastre, Michael Schotsaert, Chandra Sruti, James E. Robinson, Akhilesh Srivastava, Felix Rabito, Xuebin Qin, Jay K. Kolls |
44 |
[GO] |
2021―Dec―20 |
Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG |
Stephan Winklmeier, Katharina Eisenhut, Damla Taskin, Heike Rübsamen, Ramona Gerhards, Celine Schneider, et al. (+8) Paul R. Wratil, Marcel Stern, Peter Eichhorn, Oliver T. Keppler, Matthias Klein, Simone Mader, Tania Kümpfel, Edgar Meinl |
45 |
[GO] |
2021―Dec―10 |
Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike |
Bailey Lubinski, Maureen H.V. Fernandes, Laura Frazier, Tiffany Tang, Susan Daniel, Diego G. Diel, et al. (+2) Javier A. Jaimes, Gary R. Whittaker |
46 |
[GO] |
2021―Dec―09 |
Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults |
Mònica Girona-Alarcon, Guillermo Argüello, Ana Esteve-Sole, Sara Bobillo-Perez, Xavier Paolo-Burgos, Elisenda Bonet-Carne, et al. (+6) Anna Mensa-Vilaró, Anna Codina, María Hernández-Garcia, Cristina Jou, Laia Alsina, Iolanda Jordan |
47 |
[GO] |
2021―Dec―08 |
Standardized two-step testing of antibody activity in COVID-19 convalescent plasma |
Pavlo Gilchuk, Isaac Thomsen, Sandra Yoder, Eric Brady, James D. Chappell, Laura J. Stevens, et al. (+16) Mark R. Denison, Rachel E. Sutton, Rita E. Chen, Laura A. VanBlargan, Naveen Suryadevara, Seth J. Zost, Jonathan Schmitz, Jill M. Pulley, Michael S. Diamond, Jillian P. Rhoads, Gordon R. Bernard, Wesley H. Self, Todd W. Rice, Allison P. Wheeler, James E. Crowe, Robert H. Carnahan |
48 |
[GO] |
2021―Dec―04 |
SARS-CoV-2 Nucleocapsid protein attenuates stress granules and interacts with mRNAs to impair host stress response |
Syed Nabeel-Shah, Hyunmin Lee, Nujhat Ahmed, Giovanni L. Burke, Shaghayegh Farhangmehr, Kanwal Ashraf, et al. (+10) Shuye Pu, Ulrich Braunschweig, Guoqing Zhong, Hong Wei, Hua Tang, Jianyi Yang, Edyta Marcon, Benjamin J. Blencowe, Zhaolei Zhang, Jack F. Greenblatt |
49 |
[GO] |
2021―Dec―03 |
Global Changes in Electricity Consumption During COVID-19 |
Elizabeth Buechler, Siobhan Powell, Tao Sun, Nicolas Astier, Chad Zanocco, Jose Bolorinos, et al. (+3) June Flora, Hilary Boudet, Ram Rajagopal |
50 |
[GO] |
2021―Dec―03 |
Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication |
Elizabeth Geerling, Amanda N. Pinski, Taylor E. Stone, Richard J. DiPaolo, Michael Z. Zulu, Kevin J. Maroney, et al. (+3) James D. Brien, Ilhem Messaoudi, Amelia K. Pinto |
51 |
[GO] |
2021―Dec―02 |
Tracking the amino acid changes of spike proteins across diverse host species of severe acute respiratory syndrome coronavirus 2 |
Srinivasulu Yerukala Sathipati, Sanjay K. Shukla, Shinn-Ying Ho |
52 |
[GO] |
2021―Nov―27 |
A Deep Learning Approach for Predicting Severity of COVID-19 Patients Using A Parsimonious Set of Laboratory Markers |
Vivek Singh, Rishi Kamaleswaran, Donald Chalfin, Antonio Buño-Soto, Janika San Roman, Edith Rojas-Kenney, et al. (+5) Ross Molinaro, Sabine von Sengbusch, Parsa Hodjat, Dorin Comaniciu, Ali Kamen |
53 |
[GO] |
2021―Nov―27 |
Host parameters and mode of infection influence outcome in SARS-CoV-2 infected hamsters |
Bryan D. Griffin, Bryce M. Warner, Mable Chan, Emelissa Valcourt, Nikesh Tailor, Logan Banadyga, et al. (+23) Anders Leung, Shihua He, Amrit S. Boese, Jonathan Audet, Wenguang Cao, Estella Moffat, Lauren Garnett, Kevin Tierney, Kaylie N. Tran, Alixandra Albietz, Kathy Manguiat, Geoff Soule, Alexander Bello, Robert Vendramelli, Jessica Lin, Yvon Deschambault, Wenjun Zhu, Heidi Wood, Samira Mubareka, David Safronetz, James E. Strong, Carissa Embury-Hyatt, Darwyn Kobasa |
54 |
[GO] |
2021―Nov―19 |
Pannexin-1 channel opening is critical for COVID-19 pathogenesis |
Ross Luu, Silvana Valdebenito, Eliana Scemes, Antonio Cibelli, David Spray, Maximiliano Rovegno, et al. (+11) Juan Tichauer, Andrea Cottignies-Calamarte, Arielle Rosenberg, Calude Capron, Sandrine Belouzard, Jean Dubuisson, Djallali Annane, Geoffroy Lorin de la Grandmaison, Elisabeth Cramer-Bordé, Morgane Bomsel, Eliseo Eugenin |
55 |
[GO] |
2021―Nov―18 |
Fluvastatin mitigates SARS-CoV-2 infection in human lung cells |
Francisco J. Zapatero-Belinchón, Rebecca Moeller, Lisa Lasswitz, Marco van Ham, Miriam Becker, Graham Brogden, et al. (+11) Ebba Rosendal, Wenjie Bi, Belén Carriquí-Madroñal, Koushikul Islam, Annasara Lenman, Antonia P. Gunesch, Jared Kirui, Thomas Pietschmann, Anna K. Överby, Lothar Jänsch, Gisa Gerold |
56 |
[GO] |
2021―Nov―18 |
Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring towards glycolysis |
Hadar Medini, Amit Zirman, Dan Mishmar |
57 |
[GO] |
2021―Nov―17 |
Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2 |
Junpei Ohtsuka, Masaki Imai, Masayuki Fukumura, Mitsuyo Maeda, Asami Eguchi, Ryoichi Ono, et al. (+6) Tadashi Maemura, Mutsumi Ito, Seiya Yamayoshi, Yosky Kataoka, Yoshihiro Kawaoka, Tetsuya Nosaka |
58 |
[GO] |
2021―Nov―11 |
Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test |
Susana Eyheramendy, Pedro A. Saa, Eduardo A. Undurraga, Carlos Valencia, Carolina López, Luis Méndez, et al. (+9) Javier Pizarro-Berdichevsky, Andrés Finkelstein-Kulka, Sandra Solari, Nicolás Salas, Pedro Bahamondes, Martín Ugarte, Pablo Barceló, Marcelo Arenas, Eduardo Agosin |
59 |
[GO] |
2021―Nov―11 |
Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors |
Lei Guo, Yan Liang, Heng Li, Huiwen Zheng, Zening Yang, Yanli Chen, et al. (+6) Xin Zhao, Jing Li, Binxiang Li, Haijing Shi, Ming Sun, Longding Liu |
60 |
[GO] |
2021―Nov―10 |
Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells |
Ria Goswami, Veronica S. Russell, Joshua J. Tu, Charlene Thomas, Philip Hughes, Francine Kelly, et al. (+6) Stephanie N. Langel, Justin Steppe, Scott M. Palmer, Timothy Haystead, Maria Blasi, Sallie R. Permar |
61 |
[GO] |
2021―Nov―01 |
Functional differences among the spike glycoproteins of multiple emerging SARS-CoV-2 variants of concern |
Qian Wang, Manoj S. Nair, Saumya Anang, Shijian Zhang, Hanh Nguyen, Yaoxing Huang, et al. (+3) Lihong Liu, David D. Ho, Joseph G. Sodroski |
62 |
[GO] |
2021―Oct―28 |
The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells |
Thushan I. de Silva, Guihai Liu, Benjamin B. Lindsey, Danning Dong, Shona C. Moore, Nienyun Sharon Hsu, et al. (+16) Dhruv Shah, Dannielle Wellington, Alexander J. Mentzer, Adrienn Angyal, Rebecca Brown, Matthew D. Parker, Zixi Ying, Xuan Yao, Lance Turtle, Susanna Dunachie, Mala K. Maini, Graham Ogg, Julian C. Knight, Yanchun Peng, Sarah L. Rowland-Jones, Tao Dong |
63 |
[GO] |
2021―Oct―25 |
Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19 |
Christoph Schultheiß, Lisa Paschold, Edith Willscher, Donjete Simnica, Anna Wöstemeier, Franziska Muscate, et al. (+6) Maxi Wass, Stephan Eisenmann, Jochen Dutzmann, Gernot Keyßer, Nicola Gagliani, Mascha Binder |
64 |
[GO] |
2021―Oct―25 |
Partial Resistance of SARS-CoV-2 Delta Variants to Vaccine-elicited Antibodies and Convalescent sera |
Takuya Tada, Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Mark J. Mulligan, Nathaniel R. Landau |
65 |
[GO] |
2021―Oct―25 |
DCcov: Repositioning of Drugs and Drug Combinations for SARS-CoV-2 Infected Lung through Constraint-Based Modeling |
Ali Kishk, Maria Pires Pacheco, Thomas Sauter |
66 |
[GO] |
2021―Oct―25 |
Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency |
Luis Eduardo R. Cunha, Adilson A. Stolet, Marcelo A. Strauch, Victor A.R. Pereira, Carlos H. Dumard, Andre M.O. Gomes, et al. (+27) Fábio L. Monteiro, Luiza M. Higa, Patrícia N.C. Souza, Juliana G. Fonseca, Francisco E. Pontes, Leonardo G.R. Meirelles, José W.M. Albuquerque, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Tulio M. Lima, Renata G.F. Alvim, Federico F. Marsili, Marcella Moreira Caldeira, Russolina B. Zingali, Guilherme A.P. de Oliveira, Thiago M.L. Souza, Alexandre S. Silva, Rodrigo Muller, Daniela del Rosário Flores Rodrigues, Luciana Jesus da Costa, Arthur Daniel R. Alves, Marcelo Alves Pinto, Andréa C. Oliveira, Herbert L.M. Guedes, Amilcar Tanuri, Leda R. Castilho, Jerson L. Silva |
67 |
[GO] |
2021―Oct―22 |
Endonuclease-based genotyping of the RBM as a method to track the emergence or evolution of SARS-CoV-2 variants |
Eva Lopez, Margot Barthélémy, Cécile Baronti, Shirley Masse, Alessandra Falchi, Fabien Durbesson, et al. (+4) Renaud Vincentelli, Xavier de Lamballerie, Rémi Charrel, Bruno Coutard |
68 |
[GO] |
2021―Oct―19 |
Effective chimeric antigen receptor T-cells (CAR-Ts) against SARS-CoV-2 |
Xueyang Guo, Alexandra Kazanova, Stephanie Thurmond, H. Uri Saragovi, Christopher E. Rudd |
69 |
[GO] |
2021―Oct―16 |
Increased gaze cueing of attention during COVID-19 lockdown |
Mario Dalmaso, Luigi Castelli, Giovanni Galfano |
70 |
[GO] |
2021―Oct―14 |
The effect of N-glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor |
Chuncui Huang, Zeshun Tan, Keli Zhao, Wenjun Zou, Hui Wang, Huanyu Gao, et al. (+4) Shiwei Sun, Dongbo Bu, Wengang Chai, Yan Li |
71 |
[GO] |
2021―Oct―08 |
Inequitable and Heterogeneous Impacts on Electricity Consumption from COVID-19 Mitigation Measures |
Jiehong Lou, Yueming (Lucy) Qiu, Arthur Lin Ku, Destenie Nock, Bo Xing |
72 |
[GO] |
2021―Oct―07 |
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease |
Bryce M. Warner, Lisa A. Santry, Alexander Leacy, Mable Chan, Phuc H. Pham, Robert Vendramelli, et al. (+26) Yanlong Pei, Nikesh Tailor, Emelissa Valcourt, Anders Leung, Shihua He, Bryan D. Griffin, Jonathan Audet, Marnie Willman, Kevin Tierney, Alixandra Albietz, Kathy L. Frost, Jacob G.E. Yates, Robert C. Mould, Lily Chan, Yeganeh Mehrani, Jason P. Knapp, Jessica A. Minott, Logan Banadyga, David Safronetz, Heidi Wood, Stephanie Booth, Pierre P. Major, Byram W. Bridle, Leonardo Susta, Darwyn Kobasa, Sarah K. Wootton |
73 |
[GO] |
2021―Oct―04 |
6-Thioguanine Blocks SARS-CoV-2 Replication by Inhibition of PLpro |
Caleb D. Swaim, Varun Dwivedi, Yi-Chieh Perng, Xu Zhao, Larissa A. Canadeo, Houda H. Harastani, et al. (+5) Tamarand L. Darling, Adrianus C.M. Boon, Deborah J. Lenschow, Viraj Kulkarni, Jon M. Huibregtse |
74 |
[GO] |
2021―Oct―04 |
The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery. |
Eleni Syrimi, Eanna Fennell, Alex Richter, Pavle Vrljicak, Richard Stark, Sascha Ott, et al. (+17) Paul G. Murray, Eslam Al-Abadi, Ashish Chikermane, Pamela Dawson, Scott Hackett, Deepthi Jyothish, Hari Krishnan Kanthimathinathan, Sean Monaghan, Prasad Nagakumar, Barnaby R. Scholefield, Steven Welch, Naeem Khan, Sian Faustini, Kate Davies, Wioleta M. Zelek, Pamela Kearns, Graham S. Taylor |
75 |
[GO] |
2021―Sep―30 |
A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19 |
Friederike Krempe, Lara Schöler, Benjamin Katschinski, Anke Herrmann, Olympia E. Anastasiou, Carina Elsner, et al. (+6) R. Stefan Ross, Friedrich Scholz, Ulf Dittmer, Peter Miethe, Vu Thuy Khanh Le-Trilling, Mirko Trilling |
76 |
[GO] |
2021―Sep―30 |
Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19 |
Na Wang, Marta Vuerich, Ahmadreza Kalbasi, Jonathon J. Graham, Eva Csizmadia, Zachary James Manickas Hill, et al. (+8) Ann Woolley, Clement David, Eric M. Miller, Kara Gorman, Jonathan L. Hecht, Shahzad Shaefi, Simon C. Robson, Maria Serena Longhi |
77 |
[GO] |
2021―Sep―30 |
A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity |
Huanhuan Zhu, Fang Zheng, Linxuan Li, Yan Jin, Yuxue Luo, Zhen Li, et al. (+19) JingYu Zeng, Ling Tang, Zilong Li, Ningyu Xia, Panhong Liu, Dan Han, Ying Shan, Xiaoying Zhu, Siyang Liu, Rong Xie, Yilin Chen, Wen Liu, Longqi Liu, Xun Xu, Jian Wang, Huanming Yang, Xia Shen, Xin Jin, Fanjun Cheng |
78 |
[GO] |
2021―Sep―29 |
SARS-CoV-2 integral membrane proteins shape the serological responses of COVID-19 patients. |
Sophie Martin, Christopher Heslan, Gwénaële Jégou, Leif A. Eriksson, Matthieu Le Gallo, Vincent Thibault, et al. (+3) Eric Chevet, Florence Godey, Tony Avril |
79 |
[GO] |
2021―Sep―27 |
The nasal symbiont Staphylococcus species restricts the transcription of SARS-CoV-2 entry factors in human nasal epithelium |
Jeong Yeon Ji, Ara Jo, Jina Won, Chan Hee Gil, Haeun Shin, Sujin Kim, et al. (+2) Yung Jin Jeon, Hyun Jik Kim |
80 |
[GO] |
2021―Sep―16 |
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells |
Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch, Peter AC. Wing, Mirjam Schilling, James M. Harris, et al. (+21) Helene Borrmann, Sophie B. Morgan, Jennifer L. Cane, Laurent Mailly, Nazia Thakur, Carina Conceicao, Harshmeena Sanghani, Laura Heydmann, Charlotte Bach, Anna Ashton, Steven Walsh, Tiong Kit Tan, Kuan-Ying A Huang, Catherine Schuster, Koichi Watashi, Timothy SC. Hinks, Aarti Jagannath, Sridhar R. Vausdevan, Dalan Bailey, Thomas F. Baumert, Jane A. McKeating |
81 |
[GO] |
2021―Sep―11 |
5-Hydroxymethyltubercidin Exhibits Potent Antiviral Activity against Flaviviruses and Coronaviruses, including SARS-CoV-2 |
Kentaro Uemura, Haruaki Nobori, Akihiko Sato, Takao Sanaki, Shinsuke Toba, Michihito Sasaki, et al. (+9) Akiho Murai, Noriko Saito-Tarashima, Noriaki Minakawa, Yasuko Orba, Hiroaki Kariwa, William W. Hall, Hirofumi Sawa, Akira Matsuda, Katsumi Maenaka |
82 |
[GO] |
2021―Sep―10 |
An Interactive Single Cell Web Portal Identifies Gene and Cell Networks in COVID-19 Host Responses |
Kang Jin, Eric E. Bardes, Alexis Mitelpunkt, Jake Y. Wang, Surbhi Bhatnagar, Soma Sengupta, et al. (+3) Daniel Pomeranz Krummel, Marc E. Rothenberg, Bruce J. Aronow |
83 |
[GO] |
2021―Sep―02 |
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B-cell depleting treatment in multiple sclerosis. |
Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, Anna Månberg, Sophia Hober, Guro Gafvelin, et al. (+6) Hans Grönlund, Peter Nilsson, Mohsen Khademi, Tomas Olsson, Fredrik Piehl, Faiez Al Nimer |
84 |
[GO] |
2021―Aug―31 |
One common enemy, a pandemic, uniting interdisciplinary teams |
Marie-Elizabeth Barabas, Rituparna Chakrabarti, Michelle Muzzio |
85 |
[GO] |
2021―Aug―26 |
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2 |
Xingyue An, Melisa Martinez-Paniagua, Ali Rezvan, Samiur Rahman Sefat, Mohsen Fathi, Shailbala Singh, et al. (+5) Sujit Biswas, Melissa Pourpak, Cassian Yee, Xinli Liu, Navin Varadarajan |
86 |
[GO] |
2021―Aug―25 |
Single Cell Transcriptome Identifies FCGR3B Upregulated Subtype of Alveolar Macrophages in Patients with Critical COVID-19 |
Nasna Nassir, Richa Tambi, Asma Bankapur, Saba Al Heialy, Noushad Karuvantevida, Hamdah Hassan Khansaheb, et al. (+24) Binte Zehra, Ghausia Begum, Reem Abdel Hameid, Awab Ahmed, Zulfa Deesi, Abdulmajeed Alkhajeh, K M Furkan Uddin, Hosneara Akter, Seyed Ali Safizadeh Shabestari, Omar Almidani, Amirul Islam, Mellissa Gaudet, Richard Kumaran Kandasamy, Tom Loney, Ahmad Abou Tayoun, Norbert Nowotny, Marc Woodbury-Smith, Proton Rahman, Wolfgang M. Kuebler, Mahmood Al Mashshadani, Jean-Laurent Casanova, Bakhrom K. Berdiev, Alawi Alsheikh-Ali, Mohammed Uddin |
87 |
[GO] |
2021―Aug―20 |
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern |
Juanjie Tang, Youri Lee, Supriya Ravichandran, Gabrielle Grubbs, Chang Huang, Charles B. Stauft, et al. (+4) Tony Wang, Basil Golding, Hana Golding, Surender Khurana |
88 |
[GO] |
2021―Aug―11 |
Distinct Lipid Metabolic Dysregulation in Asymptomatic COVID-19 |
Yanhong Hao, Zheng Zhang, Guifang Feng, Moran Chen, Qiongqiong Wan, Jie Lin, et al. (+3) Liang Wu, Wenjing Nie, Suming Chen |
89 |
[GO] |
2021―Aug―09 |
Sensitive extraction-free SARS-CoV-2 RNA virus detection using a chelating resin |
Bin Guan, Karen M. Frank, José O. Maldonado, Margaret Beach, Eileen Pelayo, Blake M. Warner, Robert B. Hufnagel |
90 |
[GO] |
2021―Aug―04 |
Immunogenicity and Protective Efficacy of an Intranasal Live-attenuated Vaccine Against SARS-CoV-2 |
Jun-Guy Park, Fatai S. Oladunni, Mohammed A. Rohaim, Jayde Whittingham-Dowd, James Tollitt, Matthew D.J. Hodges, et al. (+13) Nadin Fathallah, Muhsref Bakri Assas, Wafaa Alhazmi, Abdullah Almilaibary, Munir Iqbal, Pengxiang Chang, Renee Escalona, Vinay Shivanna, Jordi B. Torrelles, John J. Worthington, Lucy H. Jackson-Jones, Luis Martinez-Sobrido, Muhammad Munir |
91 |
[GO] |
2021―Jul―31 |
Longitudinal analysis of SARS-CoV-2 seroprevalence using multiple serology platforms |
Juan Manuel Carreño, Damodara Rao Mendu, Viviana Simon, Masood A. Shariff, Gagandeep Singh, Vidya Menon, Florian Krammer |
92 |
[GO] |
2021―Jul―30 |
JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules |
Jakub Jankowski, Hye Kyung Lee, Julia Wilflingseder, Lothar Hennighausen |
93 |
[GO] |
2021―Jul―26 |
A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes |
Daniel Todt, Toni Luise Meister, Barbora Tamele, John Howes, Dajana Paulmann, Britta Becker, et al. (+12) Florian H. Brill, Mark Wind, Jack Schijven, Natalie Heinen, Volker Kinast, Baxolele Mhlekude, Christine Goffinet, Adalbert Krawczyk, Jörg Steinmann, Stephanie Pfaender, Yannick Brüggemann, Eike Steinmann |
94 |
[GO] |
2021―Jul―22 |
Effect of time and titer in convalescent plasma therapy for COVID-19 |
Paola de Candia, Francesco Prattichizzo, Silvia Garavelli, Rosalba La Grotta, Annunziata De Rosa, Agostina Pontarelli, et al. (+3) Roberto Parrella, Antonio Ceriello, Giuseppe Matarese |
95 |
[GO] |
2021―Jul―21 |
A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples |
Tiantian Liu, Zhong Chen, Wanqiu Chen, Xin Chen, Maryam Hosseini, Zhaowei Yang, et al. (+6) Jing Li, Diana Ho, David Turay, Ciprian P. Gheorghe, Wendell Jones, Charles Wang |
96 |
[GO] |
2021―Jul―14 |
The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir |
Yan Zhao, Jing Sun, Yunfei Li, Zhengxuan Li, Yu Xie, Ruoqing Feng, et al. (+2) Jincun Zhao, Yuhui Hu |
97 |
[GO] |
2021―Jul―10 |
Sensor Array and Gas Chromatographic Detection of the Blood Serum Volatolomic Signature of COVID-19 |
Yolande Ketchanji Mougang, Lorena Di Zazzo, Marilena Minieri, Rosamaria Capuano, Alexandro Catini, Jacopo Maria Legramente, et al. (+3) Roberto Paolesse, Sergio Bernardini, Corrado Di Natale |
98 |
[GO] |
2021―Jul―09 |
Multi-Omics analysis of respiratory specimen characterizes baseline molecular determinants which associate with SARS-CoV-2 infection and outcome. |
Jaswinder Singh Maras, Shvetank Sharma, Adil Bhat, Sheetalnath Rooge, Reshu aggrawal, Ekta Gupta, Shiv K. Sarin |
99 |
[GO] |
2021―Jun―26 |
Graphene Nanoplatelet and Graphene Oxide Functionalization of Face Mask Materials Inhibits Infectivity of Trapped SARS-CoV-2 |
Flavio De Maio, Valentina Palmieri, Gabriele Babini, Alberto Augello, Ivana Palucci, Giordano Perini, et al. (+10) Alessandro Salustri, Patricia Spilman, Marco De Spirito, Maurizio Sanguinetti, Giovanni Delogu, Laura Giorgia Rizzi, Giulio Cesareo, Patrick Soon-Shiong, Michela Sali, Massimiliano Papi |
100 |
[GO] |
2021―Jun―24 |
Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance |
Patrick J. Lenehan, Eshwan Ramudu, A.J. Venkatakrishnan, Gabriela Berner, Reid McMurry, John C. O’Horo, et al. (+4) Andrew D. Badley, William Morice, John Halamka, Venky Soundararajan |
101 |
[GO] |
2021―Jun―24 |
ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion |
Qiangmin Zhang, Julia Gefter, W. Bruce Sneddon, Tatyana Mamonova, Peter A. Friedman |
102 |
[GO] |
2021―Jun―19 |
Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19 |
Marcel S. Woo, Friedrich Haag, Axel Nierhaus, Dominik Jarczak, Kevin Roedl, Christina Mayer, et al. (+14) Thomas T. Brehm, Marc van der Meirschen, Annette Hennigs, Maximilian Christopeit, Walter Fiedler, Panagiotis Karagiannis, Christoph Burdelski, Alexander Schultze, Samuel Huber, Marylyn M. Addo, Stefan Schmiedel, Manuel A. Friese, Stefan Kluge, Julian Schulze zur Wiesch |
103 |
[GO] |
2021―Jun―17 |
Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution |
Kalon J. Overholt, Jonathan R. Krog, Ivan Zanoni, Bryan D. Bryson |
104 |
[GO] |
2021―Jun―10 |
Disease-dependent interaction policies to support health and economic outcomes during the COVID-19 epidemic |
Guanlin Li, Shashwat Shivam, Michael E. Hochberg, Yorai Wardi, Joshua S. Weitz |
105 |
[GO] |
2021―Jun―10 |
CD177, a specific marker of neutrophil activation, is associated with COVID-19 severity and death |
Yves Lévy, Aurélie Wiedemann, Boris P. Hejblum, Mélany Durand, Cécile Lefebvre, Mathieu Surénaud, et al. (+17) Christine Lacabaratz, Matthieu Perreau, Emile Foucat, Marie Déchenaud, Pascaline Tisserand, Fabiola Blengio, Benjamin Hivert, Marine Gauthier, Minerva Cervantes-Gonzalez, Delphine Bachelet, Cédric Laouénan, Lila Bouadma, Jean-François Timsit, Yazdan Yazdanpanah, Giuseppe Pantaleo, Hakim Hocini, Rodolphe Thiébaut |
106 |
[GO] |
2021―Jun―09 |
A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens |
Ebony N. Gary, Bryce M. Warner, Elizabeth M. Parzych, Bryan D. Griffin, Xizhou Zhu, Nikesh Tailor, et al. (+21) Nicholas J. Tursi, Mable Chan, Mansi Purwar, Robert Vendramelli, Jihae Choi, Kathy L. Frost, Sophia Reeder, Kevin Liaw, Edgar Tello, Ali R. Ali, Kun Yun, Yanlong Pei, Sylvia P. Thomas, Amira D. Rghei, Matthew M. Guilleman, Kar Muthumani, Trevor Smith, Sarah K. Wootton, Ami Patel, David B. Weiner, Darwyn Kobasa |
107 |
[GO] |
2021―Jun―01 |
Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain |
Chao Wu, Abraham J. Qavi, Asmaa Hachim, Niloufar Kavian, Aidan R. Cole, Austin B. Moyle, et al. (+10) Nicole D. Wagner, Joyce Sweeney-Gibbons, Henry W. Rohrs, Michael L. Gross, J. S. Malik Peiris, Christopher F. Basler, Christopher W. Farnsworth, Sophie A. Valkenburg, Gaya K. Amarasinghe, Daisy W. Leung |
108 |
[GO] |
2021―May―24 |
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals |
Peter V. Coyle, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al Molawi, Reham Awni El Kahlout, Imtiaz Gilliani, et al. (+18) Nourah Younes, Ghada Ali A.A. Al Anssari, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A. Butt, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed Ghaith Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Roberto Bertollini, Laith J. Abu-Raddad |
109 |
[GO] |
2021―May―18 |
Phenome-wide and eQTL Associations of COVID-19 Genetic Risk Loci |
Chang Moon, Brian M. Schilder, Towfique Raj, Kuan-lin Huang |
110 |
[GO] |
2021―May―07 |
Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids |
Huaying Zhao, Di Wu, Ai Nguyen, Yan Li, Regina C. Adão, Eugene Valkov, et al. (+3) George H. Patterson, Grzegorz Piszczek, Peter Schuck |
111 |
[GO] |
2021―May―01 |
Comparative Analysis of Antibodies to SARS-CoV-2 between Asymptomatic and Convalescent Patients |
Connor J. Dwyer, Colleen A. Cloud, Cindy Wang, Philip Heidt, Paramita Chakraborty, Tara F. Duke, et al. (+21) Shannon McGue, Braxton Jeffcoat, Jaclyn Dunne, Logan Johnson, Seungho Choi, Georges J. Nahhas, Amy S. Gandy, Nikolina Babic, Frederick S. Nolte, Philip Howe, Besim Ogretmen, Vamsi K. Gangaraju, Stephen Tomlinson, Brian Madden, Tracy Bridges, Patrick A. Flume, John Wrangle, Mark P. Rubinstein, Prabhakar K. Baliga, Satish N. Nadig, Shikhar Mehrotra |
112 |
[GO] |
2021―Apr―26 |
Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses |
Arinjay Banerjee, Nader El-Sayes, Patrick Budylowski, Rajesh Abraham Jacob, Daniel Richard, Hassaan Maan, et al. (+22) Jennifer A. Aguiar, Wael L. Demian, Kaushal Baid, Michael R. D’Agostino, Jann Catherine Ang, Tetyana Murdza, Benjamin J.-M. Tremblay, Sam Afkhami, Mehran Karimzadeh, Aaron T. Irving, Lily Yip, Mario Ostrowski, Jeremy A. Hirota, Robert Kozak, Terence D. Capellini, Matthew S. Miller, Bo Wang, Samira Mubareka, Allison J. McGeer, Andrew G. McArthur, Andrew C. Doxey, Karen Mossman |
113 |
[GO] |
2021―Apr―26 |
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice |
Tal Noy-Porat, Adva Mechaly, Yinon Levy, Efi Makdasi, Ron Alcalay, David Gur, et al. (+18) Moshe Aftalion, Reut Falach, Shani Leviatan Ben-Arye, Shirley Lazar, Ayelet Zauberman, Eyal Epstein, Theodor Chitlaru, Shay Weiss, Hagit Achdout, Jonathan D. Edgeworth, Raghavendra Kikkeri, Hai Yu, Xi Chen, Shmuel Yitzhaki, Shmuel C. Shapira, Vered Padler-Karavani, Ohad Mazor, Ronit Rosenfeld |
114 |
[GO] |
2021―Apr―21 |
Cell type resolved quantitative proteomics map of interferon response against SARS-CoV-2 |
Elisa Saccon, Xi Chen, Flora Mikaeloff, Jimmy Esneider Rodriguez, Laszlo Szekely, Beatriz Sá Vinhas, et al. (+7) Shuba Krishnan, Siddappa N. Byrareddy, Teresa Frisan, Ákos Végvári, Ali Mirazimi, Ujjwal Neogi, Soham Gupta |
115 |
[GO] |
2021―Apr―19 |
Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells |
Emi Sano, Sayaka Deguchi, Ayaka Sakamoto, Natsumi Mimura, Ai Hirabayashi, Yukiko Muramoto, et al. (+3) Takeshi Noda, Takuya Yamamoto, Kazuo Takayama |
116 |
[GO] |
2021―Mar―19 |
Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19 |
Immacolata Andolfo, Roberta Russo, Vito Alessandro Lasorsa, Sueva Cantalupo, Barbara Eleni Rosato, Ferdinando Bonfiglio, et al. (+15) Giulia Frisso, Pasquale Abete, Gian Marco Cassese, Giuseppe Servillo, Gabriella Esposito, Ivan Gentile, Carmelo Piscopo, Romolo Villani, Giuseppe Fiorentino, Pellegrino Cerino, Carlo Buonerba, Biancamaria Pierri, Massimo Zollo, Achille Iolascon, Mario Capasso |
117 |
[GO] |
2021―Mar―19 |
Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-COV-2 |
Ang Gao, Zhilin Chen, Assaf Amitai, Julia Doelger, Vamsee Mallajosyula, Emily Sundquist, et al. (+6) Florencia Pereyra Segal, Mary Carrington, Mark M. Davis, Hendrik Streeck, Arup K. Chakraborty, Boris Julg |
118 |
[GO] |
2021―Mar―14 |
The Silent Pandemic: Emergent Antibiotic Resistances Following the Global Response to SARS-CoV-2 |
Andrew R. Mahoney, Mohammad Moein Safaee, William M. Wuest, Ariel L. Furst |
119 |
[GO] |
2021―Mar―10 |
SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway |
Grant R. Campbell, Rachel K. To, Jonathan Hanna, Stephen A. Spector |
120 |
[GO] |
2021―Mar―10 |
Title: ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway |
Xiaoyuan Lin, Beibei Fu, Songna Yin, Zhifeng Li, Huawen Liu, Haiwei Zhang, et al. (+12) Na Xing, Yu Wang, Weiwei Xue, Yan Xiong, Shanfu Zhang, Qingting Zhao, Shiyao Xu, Jing Zhang, Peihui Wang, Weiqi Nian, Xingsheng Wang, Haibo Wu |
121 |
[GO] |
2021―Mar―07 |
A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection |
Jane E. Sinclair, Yanshan Zhu, Gang Xu, Wei Ma, Haiyan Shi, Kun-Long Ma, et al. (+9) Chun-Feng Cao, Ling-Xi Kong, Ke-Qiang Wan, Juan Liao, Hai-Qiang Wang, Matt Arentz, Meredith A. Redd, Linda A. Gallo, Kirsty R. Short |
122 |
[GO] |
2021―Mar―01 |
Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19 |
Qu Deng, Reyaz ur Rasool, Ronnie M. Russell, Ramakrishnan Natesan, Irfan A. Asangani |
123 |
[GO] |
2021―Feb―23 |
Heuristic Thinking and Altruism towards Machines in People Impacted by Covid-19 |
Celso M. de Melo, Jonathan Gratch, Frank Krueger |
124 |
[GO] |
2021―Feb―16 |
Pre-existing conditions in Hispanics/Latinxs that are COVID-19 risk factors |
Timothy S. Chang, Yi Ding, Malika K. Freund, Ruth Johnson, Tommer Schwarz, Julie M. Yabu, et al. (+6) Chad Hazlett, Jeffrey N. Chiang, David A. Wulf, Daniel H. Geschwind, Manish J. Butte, Bogdan Pasaniuc |
125 |
[GO] |
2021―Feb―16 |
Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes |
Ziliang Zhou, Chunliu Huang, Zhechong Zhou, Zhaoxia Huang, Lili Su, Sisi Kang, et al. (+7) Xiaoxue Chen, Qiuyue Chen, Suhua He, Xia Rong, Fei Xiao, Jun Chen, Shoudeng Chen |
126 |
[GO] |
2021―Feb―10 |
Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without |
Samuel A. Theuerkauf, Alexander Michels, Vanessa Riechert, Thorsten J. Maier, Egbert Flory, Klaus Cichutek, Christian J. Buchholz |
127 |
[GO] |
2021―Feb―07 |
Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy |
Wyler Emanuel, Mösbauer Kirstin, Franke Vedran, Diag Asija, Gottula Lina Theresa, Arsiè Roberto, et al. (+22) Klironomos Filippos, Koppstein David, Hönzke Katja, Ayoub Salah, Buccitelli Christopher, Hoffmann Karen, Richter Anja, Legnini Ivano, Ivanov Andranik, Mari Tommaso, Del Giudice Simone, Papies Jan, Praktiknjo Samantha, F. Meyer Thomas, Müller Marcel Alexander, Niemeyer Daniela, Hocke Andreas, Selbach Matthias, Akalin Altuna, Rajewsky Nikolaus, Drosten Christian#, Landthaler Markus |
128 |
[GO] |
2021―Feb―06 |
Proteomic Investigation Reveals Dominant Alterations of Neutrophil Degranulation and mRNA Translation Pathways in COVID-19 Patients |
Renuka Bankar, Kruthi Suvarna, Saicharan Ghantasala, Arghya Banerjee, Deeptarup Biswas, Manisha Choudhury, et al. (+13) P. Viswanthram, Akanksha Salkar, Ayushi Verma, Avinash Singh, Amrita Mukherjee, Medha Gayathri J. Pai, Jyotirmoy Roy, Alisha Srivastava, Apoorva Badaya, Sachee Agrawal, Om Shrivastav, Jayanti Shastri, Sanjeeva Srivastava |
129 |
[GO] |
2021―Jan―28 |
Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity |
Alex Graudenzi, Davide Maspero, Fabrizio Angaroni, Rocco Piazza, Daniele Ramazzotti |
130 |
[GO] |
2021―Jan―22 |
The presentation of SARS-CoV-2 peptides by the common HLA-A*02:01 molecule |
Christopher Szeto, Demetra S.M. Chatzileontiadou, Andrea T. Nguyen, Hannah Sloane, Christian A. Lobos, Dhilshan Jayasinghe, et al. (+5) Hanim Halim, Corey Smith, Alan Riboldi-Tunnicliffe, Emma J. Grant, Stephanie Gras |
131 |
[GO] |
2021―Jan―20 |
The outbreak of COVID-19 altered the relationship between current negative memory biases and future depressive degree in nonclinical depression |
Pengyu Zhang, Yi Piao, Ying Chen, Jiecheng Ren, Longhua Zhang, Bensheng Qiu, et al. (+2) Zhengde Wei, Xiaochu Zhang |
132 |
[GO] |
2021―Jan―12 |
A high-throughput liquid bead-array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity |
Monique Bennett, Sandra Yoder, Eric Brady, Jill M. Pulley, Jillian P. Rhoads, Thomas G. Stewart, et al. (+4) Gordon R. Bernard, C. Buddy Creech, Allison P. Wheeler, Isaac Thomsen |
133 |
[GO] |
2021―Jan―10 |
A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening |
Christoph Gorgulla, Krishna M. Padmanabha Das, Kendra E. Leigh, Marco Cespugli, Patrick D. Fischer, Zi-Fu Wang, et al. (+31) Guilhem Tesseyre, Shreya Pandita, Alec Shnapir, Anthony Calderaio, Minko Gechev, Alexander Rose, Noam Lewis, Colin Hutcheson, Erez Yaffe, Roni Luxenburg, Henry D. Herce, Vedat Durmaz, Thanos D. Halazonetis, Konstantin Fackeldey, Justin J. Patten, Alexander Chuprina, Igor Dziuba, Alla Plekhova, Yurii Moroz, Dmytro Radchenko, Olga Tarkhanova, Irina Yavnyuk, Christian Gruber, Ryan Yust, Dave Payne, Anders M. Näär, Mark N. Namchuk, Robert A. Davey, Gerhard Wagner, Jamie Kinney, Haribabu Arthanari |
134 |
[GO] |
2020―Dec―27 |
High-Throughput Rational Design of the Remdesivir Binding Site in the RdRp of SARS-CoV-2: Implications for Potential Resistance |
Aditya K. Padhi, Rohit Shukla, Prakash Saudagar, Timir Tripathi |
135 |
[GO] |
2020―Dec―16 |
Transcriptomic Similarities and Differences in Host Response between SARS-CoV-2 and Other Viral Infections |
Simone A. Thair, Yudong D. He, Yehudit Hasin-Brumshtein, Suraj Sakaram, Rushika Pandya, Jiaying Toh, et al. (+13) David Rawling, Melissa Remmel, Sabrina Coyle, George N. Dalekos, Ioannis Koutsodimitropoulos, Glykeria Vlachogianni, Eleni Gkeka, Eleni Karakike, Georgia Damoraki, Nikolaos Antonakos, Purvesh Khatri, Evangelos J. Giamarellos-Bourboulis, Timothy E. Sweeney |
136 |
[GO] |
2020―Dec―07 |
Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19 |
Lucy CK. Bell, Cem Meydan, Jacob Kim, Jonathan Foox, Daniel Butler, Christopher E. Mason, et al. (+3) Sagi D. Shapira, Mahdad Noursadeghi, Gabriele Pollara |
137 |
[GO] |
2020―Dec―07 |
Structural characterization of Nonstructural protein 1 from SARS-CoV-2 |
Cameron Semper, Nobuhiko Watanabe, Alexei Savchenko |
138 |
[GO] |
2020―Nov―28 |
Remdesivir is effective in combating COVID-19 because it is a better substrate than ATP for the viral RNA-dependent RNA polymerase |
Tyler L. Dangerfield, Nathan Z. Huang, Kenneth A. Johnson |
139 |
[GO] |
2020―Nov―25 |
SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain |
Leon Fodoulian, Joel Tuberosa, Daniel Rossier, Madlaina Boillat, Chenda Kan, Véronique Pauli, et al. (+5) Kristof Egervari, Johannes A. Lobrinus, Basile N. Landis, Alan Carleton, Ivan Rodriguez |
140 |
[GO] |
2020―Nov―13 |
Innate and adaptive immunity of murine neural stem cell-derived piRNA exosomes/microvesicles against pseudotyped SARS-CoV-2 and HIV-based lentivirus |
Bin Yu, Shoeb Ikhlas, Chunsheng Ruan, Xingxing Zhong, Dongsheng Cai |
141 |
[GO] |
2020―Oct―28 |
The SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and Furin proteases |
Lulin Zhou, Zubiao Niu, Xiaoyi Jiang, Zhengrong Zhang, You Zheng, Zhongyi Wang, et al. (+5) Yichao Zhu, Lihua Gao, Hongyan Huang, Xiaoning Wang, Qiang Sun |
142 |
[GO] |
2020―Oct―26 |
Robust and specific secretory IgA against SARS-CoV-2 detected in human milk |
Alisa Fox, Jessica Marino, Fatima Amanat, Florian Krammer, Jennifer Hahn-Holbrook, Susan Zolla-Pazner, Rebecca L. Powell |
143 |
[GO] |
2020―Oct―05 |
Furin, a potential therapeutic target for COVID-19 |
Canrong Wu, Mengzhu Zheng, Yueying Yang, Xiaoxia Gu, Kaiyin Yang, Mingxue Li, et al. (+10) Yang Liu, Qingzhe Zhang, Peng Zhang, Yali Wang, Qiqi Wang, Yang Xu, Yirong Zhou, Yonghui Zhang, Lixia Chen, Hua Li |
144 |
[GO] |
2020―Oct―05 |
Impact of COVID-19 measures on short-term electricity consumption in the most affected EU countries and USA states |
Javier López Prol, Sungmin O |
145 |
[GO] |
2020―Oct―05 |
SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum |
Chiara Bruzzone, Maider Bizkarguenaga, Rubén Gil-Redondo, Tammo Diercks, Eunate Arana, Aitor García de Vicuña, et al. (+13) Marisa Seco, Alexandre Bosch, Asís Palazón, Itxaso San Juan, Ana Laín, Jon Gil-Martínez, Ganeko Bernardo-Seisdedos, David Fernández-Ramos, Fernando Lopitz-Otsoa, Nieves Embade, Shelly Lu, José M. Mato, Oscar Millet |
146 |
[GO] |
2020―Sep―29 |
Mitochondria - in the crossfire of SARS-CoV-2 and immunity |
Johannes Burtscher, Giuseppe Cappellano, Akiko Omori, Takumi Koshiba, Grégoire P. Millet |
147 |
[GO] |
2020―Sep―25 |
PPARγ cistrome repression during activation of lung monocyte-macrophages in severe COVID-19 |
Christophe Desterke, Ali G. Turhan, Annelise Bennaceur-Griscelli, Frank Griscelli |
148 |
[GO] |
2020―Sep―23 |
SARS-CoV-2 infection boosts MX1 antiviral effector in COVID-19 patients |
Juan Bizzotto, Pablo Sanchis, Mercedes Abbate, Sofía Lage-Vickers, Rosario Lavignolle, Ayelén Toro, et al. (+6) Santiago Olszevicki, Agustina Sabater, Florencia Cascardo, Elba Vazquez, Javier Cotignola, Geraldine Gueron |
149 |
[GO] |
2020―Sep―03 |
Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis |
Nilesh Kumar, Bharat Mishra, Adeel Mehmood, Mohammad Athar |
150 |
[GO] |
2020―Jul―31 |
ACE2, Metformin, and COVID-19 |
Atul Malhotra, Mark Hepokoski, Karen C. McCowen, John Y-J Shyy |
151 |
[GO] |
2020―Jul―28 |
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike |
Yu Li, Ziding Zhang, Li Yang, Xianyi Lian, Yan Xie, Shen Li, et al. (+3) Shuyu Xin, Pengfei Cao, Jianhong Lu |
152 |
[GO] |
2020―Jul―25 |
Molecular and immunological diagnostic tests of COVID-19 - current status and challenges |
Tugba Kilic, Ralph Weissleder, Hakho Lee |
153 |
[GO] |
2020―Jul―18 |
ACE2 co-evolutionary pattern suggests targets for pharmaceutical intervention in the COVID-19 pandemic |
Maya Braun, Elad Sharon, Irene Unterman, Maya Miller, Anna Mellul Shtern, Shmuel Benenson, et al. (+2) Alexander Vainstein, Yuval Tabach |
154 |
[GO] |
2020―Jun―20 |
Current status of COVID-19 therapies and drug repositioning applications |
Ozlem Altay, Elyas Mohammadi, Simon Lam, Hasan Turkez, Jan Boren, Jens Nielsen, et al. (+2) Mathias Uhlen, Adil Mardinoglu |
155 |
[GO] |
2020―Jun―20 |
CORDITE: the curated CORona Drug InTERactions database for SARS-CoV-2 |
Roman Martin, Hannah F. Löchel, Marius Welzel, Georges Hattab, Anne-Christin Hauschild, Dominik Heider |
156 |
[GO] |
2020―Jun―09 |
Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9 |
Dene R. Littler, Benjamin S. Gully, Rhys N. Colson, Jamie Rossjohn |
157 |
[GO] |
2020―May―30 |
Mitigating coronavirus-induced acute respiratory distress syndrome by radiotherapy |
Jian Jian Li |
158 |
[GO] |
2020―May―28 |
Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site |
Javier A. Jaimes, Jean K. Millet, Gary R. Whittaker |
159 |
[GO] |
2020―May―13 |
The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike |
Yu Li, Ziding Zhang, Li Yang, Xianyi Lian, Yan Xie, Shen Li, et al. (+3) Shuyu Xin, Pengfei Cao, Jianhong Lu |
160 |
[GO] |
2020―May―12 |
In the Race to Help with Covid-19, Time Is Precious: Editorial Guidelines for Coronavirus Papers |
Simona Fiorani, Stefano Tonzani |
|